Juan Carhuapoma

Associate Professor

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 16 Similar Profiles
Cerebral Hemorrhage Medicine & Life Sciences
Subarachnoid Hemorrhage Medicine & Life Sciences
Hematoma Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Brain Edema Medicine & Life Sciences
Critical Care Medicine & Life Sciences
Edema Medicine & Life Sciences
Stroke Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2018


Multimodality MRI assessment of grey and white matter injury and blood-brain barrier disruption after intracerebral haemorrhage in mice

Yang, J., Li, Q., Wang, Z., Qi, C., Han, X., Lan, X., Wan, J., Wang, W., Zhao, X., Hou, Z., Gao, C., Carhuapoma, J., Mori, S., Zhang, J. & Wang, J., Jan 13 2017, In : Scientific Reports. 7, 40358.

Research output: Contribution to journalArticle

Cerebral Hemorrhage
Blood-Brain Barrier
Corpus Striatum
Wounds and Injuries

Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial

CLEAR III Investigators, Feb 11 2017, In : The Lancet. 389, 10069, p. 603-611 9 p.

Research output: Contribution to journalArticle

Tissue Plasminogen Activator
Odds Ratio

Cocaine use as an independent predictor of seizures after aneurysmal subarachnoid hemorrhage

Chang, T. R., Kowalski, R. G., Carhuapoma, J., Tamargo, R. J. & Naval, N. S., Mar 1 2016, In : Journal of Neurosurgery. 124, 3, p. 730-735 6 p.

Research output: Contribution to journalArticle

Subarachnoid Hemorrhage
Cerebral Hemorrhage
Intracranial Aneurysm

Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial

Hanley, D. F., Thompson, R., Muschelli, J., Rosenblum, M. A., McBee, N., Lane, K., Bistran-Hall, A. J., Mayo, S., Keyl, P., Gandhi, D., Morgan, T. C., Ullman, N., Mould, W. A., Carhuapoma, J., Kase, C., Ziai, W. C., Thompson, C., Yenokyan, G., Huang, E., Broaddus, W. C. & 14 othersGraham, R. S., Aldrich, E. F., Dodd, R., Wijman, C., Caron, J. L., Huang, J., Camarata, P., Mendelow, A. D., Gregson, B., Janis, S., Vespa, P., Martin, N., Awad, I. & Zuccarello, M., Nov 1 2016, In : The Lancet Neurology. 15, 12, p. 1228-1237 10 p.

Research output: Contribution to journalArticle

Minimally Invasive Surgical Procedures
Cerebral Hemorrhage
Tissue Plasminogen Activator